ArticleJCO precision oncology2019

Atypical, Non-V600 BRAF Mutations as a Potential Mechanism of Resistance to EGFR Inhibition in Metastatic Colorectal Cancer.

Benny Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.